SCYNEXIS, Inc. (SCYX)
NASDAQ: SCYX · Real-Time Price · USD
0.9700
-0.0300 (-3.00%)
Mar 31, 2025, 10:57 AM EDT - Market open
SCYNEXIS Market Cap
SCYNEXIS has a market cap or net worth of $37.81 million as of March 31, 2025. Its market cap has decreased by -33.55% in one year.
Market Cap
37.81M
Enterprise Value
-4.05M
1-Year Change
-33.55%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since May 2, 2014, SCYNEXIS's market cap has decreased from $76.10M to $37.81M, a decrease of -50.31%. That is a compound annual growth rate of -6.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 39.00M | -15.03% |
| Dec 31, 2024 | 45.90M | -44.70% |
| Dec 29, 2023 | 83.00M | 63.06% |
| Dec 30, 2022 | 50.90M | -65.16% |
| Dec 31, 2021 | 146.10M | 74.55% |
| Dec 31, 2020 | 83.70M | 57.63% |
| Dec 31, 2019 | 53.10M | 129.87% |
| Dec 31, 2018 | 23.10M | -65.16% |
| Dec 29, 2017 | 66.30M | -13.33% |
| Dec 30, 2016 | 76.50M | -11.46% |
| Dec 31, 2015 | 86.40M | 1.65% |
| Dec 31, 2014 | 85.00M | 11.70% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 723.36B |
| UnitedHealth Group | 479.26B |
| Johnson & Johnson | 400.85B |
| AbbVie | 370.84B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 229.14B |
| Merck & Co. | 225.30B |